We are ranked among one of the best children's hospitals in the country for pediatric neurology and neurosurgery, according to U.S. News & World Report. We combine our expertise of diagnosing and treating disorders of the nervous system with an understanding of childhood medical disorders and the special needs of children and their families.
If your child has problems involving the nervous system, we have the special training and experience to treat him. In many cases, we work as a team with pediatricians and other primary care doctors. We also work closely with other pediatric specialists as needed, such as behavioral and neuropsychologists, developmental and behavioral pediatricians and pediatric neurosurgeons, to care for children who have more complex or serious medical issues. These include epilepsy, birth defects and mental retardation.
We use a variety of tests and procedures to obtain an accurate diagnosis, such as cerebral angiography, EEG, EMG, nerve conduction velocity testing and transcranial Doppler. We may also use neuropsychological testing to assess cognitive development and function.
We stay up on the latest advances in the treatment of neurologic conditions, such as a ketogenic diet for reducing the number of seizures associated with epilepsy or cognitive behavioral therapy and biofeedback training for managing chronic headaches, to ensure your child gets the most effective and up-to-date therapies to meet her individual needs.
Among the range of conditions we diagnose and treat are:
Director, Pediatric Neurology; Co-director, Tuberous Sclerosis Program; Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Co-director, Tuberous Sclerosis Clinic, Pediatric Neurologist
Pediatric Nurse Practitioner
Director, NeuroDevelopmental Science Center; Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Coordinator, Epilepsy Surgery Program; Pediatric Nurse Practitioner
Pediatric Neurologist
Pediatric Neurologist
Pediatric Nurse Practitioner
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Pediatric Neurologist/Epileptologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Pediatric Neurologist
Pediatric Neurologist
Director, Headache Program; Pediatric Neurologist
Director, Pediatric Epileptology; Pediatric Neurologist/Epileptologist
Epilepsy is often controlled by current medications. For some children, however, these medicines do not fully control their seizures. Or, these medicines may cause side effects. In this study we want to find out if a medicine (pregabalin) helps reduce partial onset seizures in children. If your child already takes antiepileptic drugs but still has seizures, we will give pregabalin as an add-on medication. Some children may receive a pill without an active drug (a placebo). We can then determine if adding pregabalin reduced seizures.
Currently recruiting
Epilepsy is often controlled by current medications. For some children, however, these medicines do not fully control their seizures. Or, these medicines may cause side effects. In this study we want to find out if a medicine (pregabalin) helps reduce partial onset seizures in children. If your child already takes antiepileptic drugs but still has seizures, we will give pregabalin as an add-on medication. Some children may receive a pill without an active drug (a placebo). We can then determine if adding pregabalin reduced seizures.
Currently recruiting
We’re trying to learn how people with mitochondrial myopathy respond to exercise. Mitochondria are the body’s "power plants." They turn food into energy. If the "power plants” don’t make enough energy, muscles may grow weak. We’re studying differences between mitochondrial myopathy patients and healthy children when exercising. An exercise test tells us about breathing, blood circulation and muscle function during exercise. Such studies may lead to exercise testing as a way to diagnose and monitor mitochondrial myopathy patients.
Currently recruiting
In this trial we are testing a medical monitoring device called the Headsense-1000 that may help diagnose and manage symptoms of a possible concussion in young athletes. A concussion or brain injury can increase the pressure in the skull and sometimes this pressure can cause serious medical problems. During this trial we will use the HeadSense monitoring device, which uses an audio signal, to record pressure of fluid inside the skulls of patients with injuries or concussions as well as patients with no injuries or concussions. Comparing the results will allow to determine if the HeadSense device has value in diagnosing and treating young athletes with head injuries.
Currently recruiting
We are conducting this study to understand the history of AHS, a rare genetic disorder that is characterized by seizures, liver dysfunction and progressive developmental regression that leads to early death. Through this study we will determine if there are connections between a patient’s medical history and onset of AHS as well as the relationship between signs and symptoms of presentation of AHS and severity and survival of AHS. Children born with this disorder will appear heathy at birth and usually develop normally until the onset of their illness. Most patients with AHS will show symptoms of this illness between 2-4 years of age and a smaller group of patients show symptoms for between 17-24 years of age. For more information on the Alpers-HuttenLocher Syndrome, visit: https://ghr.nlm.nih.gov/condition/alpers-huttenlocher-syndrome#diagnosis For complete study information, visit: https://clinicaltrials.gov/ct2/show/NCT03034512?term=alpers-huttenlocher&rank=1
Currently recruiting
For complete study information, please visit clinicaltrials.gov.
Currently recruiting
For complete study information, please visit clinicaltrials.gov.
Currently recruiting
For complete study information, please view the study on clinicaltrials.gov
Currently recruiting
For complete information, please view the study on clinicaltrials.gov
Currently recruiting
For complete information, please view the study on clinicaltrials.gov
Currently recruiting
Epilepsy is the most common neurologic disorder in children affecting 4-6 per 1000 children Antiepileptic drugs (AEDs) are the primary, and frequently exclusive, treatment option for epilepsy. While necessary and effective for seizure control, AEDs can also cause neurotoxicity, adversely affecting functioning of the central nervous system. This study aims to evaluate patients before starting AED’s to evaluate any possible side effects or difference in the child’s ability to perform certain tasks (cognitive functioning) The purpose of the proposed study is to examine the cognitive and behavioral effects of commonly prescribed AEDs on children with new onset seizures. This will be accomplished by recruiting children who are seen in the new onset seizure clinic in the Neurology service of the Neuro Developmental Science Center (NDSC) at Akron Children’s Hospital.
Currently recruiting
Watch Video:
"A bright star" - 2017 Advertising Campaign
Watch Video:
"Never alone" - 2017 Advertising Campaign
Watch Video:
Hospital surgeon scales Mt. Kilimanjaro (WEWS)
Watch Video:
Expert offers input into Charlie Gard case (HLN)
Watch Video:
Fighting for Baby Charlie (HLN)
